Weiss, T., Carr, R. D., Pal, S., Yang, L., Sawhney, B., Boggs, R., . . . Iglay, K. (2020). Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States. Patient Prefer Adherence.
Chicago Style aipamenaWeiss, Tracey, Richard D. Carr, Sampriti Pal, Lingfeng Yang, Baanie Sawhney, Robert Boggs, Swapnil Rajpathak, and Kristy Iglay. "Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States." Patient Prefer Adherence 2020.
MLA aipamenaWeiss, Tracey, et al. "Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States." Patient Prefer Adherence 2020.